Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

The first hematopoietic transplant in which umbilical cord blood (UCB) was used as the
source of hematopoietic cells was performed in October 1988. Since then, significant …

Previously, two men were cured of HIV-1 through CCR5Δ32 homozygous (CCR5Δ32/Δ32)
allogeneic adult stem cell transplant. We report the first remission and possible HIV-1 cure in …

Umbilical cord blood (UCB) is a valuable source of hematopoietic stem cells (HSCs) for use
in allogeneic transplantation. Key advantages of UCB are rapid availability and less …

Allogeneic hematopoietic cell transplantation is increasingly utilized in older adults. This
study prospectively evaluated the prognostic utility of geriatric assessment domains prior to …

Unrelated donor cord blood transplantation (CBT) results in disease-free survival
comparable to that of unrelated adult donor transplantation in patients with hematologic …

Umbilical cord blood (UCB) is an important source of hematopoietic stem cells (HSC) for
allogeneic transplantation when HLA-matched sibling and unrelated donors (MUD) are …

Only 30% of patients who require an allogeneic hematopoietic cell transplant will have an
HLA-matched sibling donor. A search for an unrelated donor will be undertaken for patients …

Limitations found on geriatric assessment (GA) track with worse outcomes after
hematopoietic cell transplantation (HCT). We report on a multidisciplinary team clinic (MDC) …

Haematopoietic cell transplantation (HCT) is the most widely used form of cellular therapy. It
is the only known cure for some haematological malignancies and has recently been used …